Clincosm LogoSign in Get a demo

Clinical and Biochemical Presentation of Polycystic Ovary Syndrome in Different Age Group

Sponsor
Taipei Medical University WanFang Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01350895
Collaborator
(none)
781
Enrollment
1
Location
14
Duration (Months)
55.9
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

To study the clinical and biochemical characteristics women with polycystic ovary syndrome (PCOS) in different aged groups.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Polycystic ovarian syndrome (PCOS) is the most frequent endocrine disorder of reproductive age women, affecting an estimated 9-18% of all women in this age group. To diagnose of PCOS in early life is especially important because it is now thought to increase metabolic and cardiovascular risks. Investigating PCOS is crucial as it is now considered to increase metabolic and cardiovascular risk, thereby impacting the health of women to a much greater extent than previously thought. We are plan using retrospective analysis to evaluate the clinical and biochemical presentation of PCOS in different aged groups.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    781 participants
    Time Perspective:
    Retrospective
    Official Title:
    Clinical and Biochemical Presentation of Polycystic Ovary Syndrome in Different Age Group
    Study Start Date :
    Feb 1, 2011
    Actual Primary Completion Date :
    Apr 1, 2012
    Actual Study Completion Date :
    Apr 1, 2012

    Arms and Interventions

    Arm Intervention/Treatment
    Experimental Group
    Control Group

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years to 46 Years
      Sexes Eligible for Study:
      Female
      Accepts Healthy Volunteers:
      Yes
      Inclusion Criteria:
      • Reproductive age women with sufficient data
      Exclusion Criteria:

      • Disorders of uterus (e.g. Asherman's Syndrome, Mullerian agenesis) and chromosomal anomalies (e.g. Turner syndrome)

      • women who had had menarche at less than 3 years of age, Day 3 FSH > 15, or who were older than 46

      • women with inadequate clinical/biochemical records

      • and women who had had ovarian cysts or ovarian tumors in ultrasonography examination

      • pregnancy women

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Taipei Medical University-WanFang Hospital Taipei Taiwan

      Sponsors and Collaborators

      • Taipei Medical University WanFang Hospital

      Investigators

      • Principal Investigator: Ming-I Hsu, Taipei Medical University WanFang Hospital

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      Ming-I Hsu, Attending Doctor, Taipei Medical University WanFang Hospital
      ClinicalTrials.gov Identifier:
      NCT01350895
      Other Study ID Numbers:
      • WFH-PCOS-100002
      First Posted:
      May 10, 2011
      Last Update Posted:
      Nov 6, 2013
      Last Verified:
      Nov 1, 2013
      Keywords provided by Ming-I Hsu, Attending Doctor, Taipei Medical University WanFang Hospital
      Polycystic ovarian syndrome (PCOS)
      Additional relevant MeSH terms:
      Polycystic Ovary Syndrome
      Syndrome

      Study Results

      No Results Posted as of Nov 6, 2013